L-Thyroxin Jod Aristo (Levothyroxine Sodium, Potassium Iodide)

L-Thyroxin Jod Aristo provides levothyroxine sodium for thyroid hormone replacement therapy, addressing conditions that involve deficient thyroid function.

• Hypothyroidism: restores normal thyroid hormone levels, alleviating symptoms such as fatigue, weight gain, and cold intolerance.
• Thyroid hormone replacement after thyroidectomy: supplies the missing thyroxine to maintain metabolic balance following surgical removal of the thyroid gland.
• Goiter: helps reduce thyroid‑stimulating hormone (TSH) drive, contributing to shrinkage of an enlarged thyroid.

• Levothyroxine sodium is a synthetic analogue of the endogenous hormone thyroxine (T4). After oral absorption, it is converted to the active triiodothyronine (T3) within peripheral tissues. The hormone binds to nuclear thyroid hormone receptors, modulating gene transcription that regulates basal metabolic rate, protein synthesis, and growth. By restoring circulating T4/T3 concentrations, the drug normalizes the hypothalamic‑pituitary‑thyroid feedback loop.

Levothyroxine therapy may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Headache: mild headache reported during dose adjustment.
• Insomnia: difficulty sleeping, especially if taken later in the day.
• Palpitations: awareness of heartbeats without underlying arrhythmia.

Serious or Rare Side Effects

• Allergic reaction: rash, itching, swelling, or anaphylaxis.
• Cardiac arrhythmia: rapid or irregular heartbeat, particularly in patients with pre‑existing heart disease.
• Hyperthyroidism: symptoms of excess thyroid hormone such as tremor, heat intolerance, and weight loss.

When prescribing L-Thyroxin Jod Aristo, clinicians should observe several safety considerations.

• Dose titration: adjust the dose gradually, especially in elderly or cardiac patients.
• Thyroid function monitoring: regularly check serum TSH and free T4 levels to maintain euthyroidism.
• Cardiovascular disease: use caution in patients with angina, arrhythmias, or recent myocardial infarction.
• Adrenal insufficiency: ensure adequate glucocorticoid replacement before initiating therapy.
• Pregnancy and lactation: evaluate risk‑benefit, as thyroid hormone is essential for fetal development.
• Store at room temperature: keep in the original container, protect from moisture and light.

Levothyroxine sodium can interact with several medications, affecting its absorption or hormonal activity.

Major Interactions (Avoid)

• Calcium carbonate or calcium supplements: bind levothyroxine and reduce its absorption.
• Iron salts (ferrous sulfate): significantly decrease levothyroxine bioavailability.
• Sucralfate or aluminum/magnesium antacids: interfere with intestinal uptake of the hormone.
• Cholestyramine and other bile‑acid sequestrants: lower levothyroxine absorption.
• Proton pump inhibitors (high dose): may modestly reduce absorption, requiring monitoring.

Moderate Interactions (Monitor Closely)

• Estrogen therapy or oral contraceptives: may increase levothyroxine requirements.
• Amiodarone: can alter thyroid hormone metabolism, necessitating dose adjustments.
• Anticonvulsants (carbamazepine, phenytoin): enhance hepatic metabolism of levothyroxine.
• Rifampin and other enzyme inducers: increase clearance of levothyroxine.
• Warfarin: levothyroxine may affect anticoagulant control, requiring INR monitoring.